Companies

Companies

featured image of Ligand Pharma Snaps Up Apeiron Biologics for $100M

Ligand Pharma Snaps Up Apeiron Biologics for $100M

BIOT

📢 Ligand Pharma acquires Apeiron Biologics for $100M, invests $4M in invIOs Holding AG, and offers future event-based considerations. 🏢💰🏥🤝📅

featured image of Exciting Partnership Expands EuroscreenFast's Reach in Korea!

Exciting Partnership Expands EuroscreenFast’s Reach in Korea!

BIOT

📢 EuroscreenFast and GW Vitek join forces in Korea, expanding market reach and offering cutting-edge GPCR screening technologies. 🤝🌍💼

featured image of Breaking News: EuroscreenFast and GW Vitek Join Forces to Revolutionize Korean Market

Breaking News: EuroscreenFast and GW Vitek Join Forces to Revolutionize Korean Market

BIOT

📢 Belgian screening specialist EuroscreenFast and Asian distributor GW Vitek join forces for strategic collaboration in Korea! 🌍🤝🚀

featured image of EMA-Gate: PharmaMar Triumphs Against Conflicts of Interest

EMA-Gate: PharmaMar Triumphs Against Conflicts of Interest

BIOT

🔍 PharmaMar wins suit against EMA experts for conflicts of interest in non-authorization of Aplidin. 💊👨‍⚖️💰 EMAGate

featured image of Evotec and Sandoz Join Forces for Biosimilar Breakthrough

Evotec and Sandoz Join Forces for Biosimilar Breakthrough

BIOT

📢 Just – Evotec Biologics expands partnership with Sandoz, providing biosimilars and enhancing patient access. 🧪🤝 BiosimilarDevelopment

featured image of Cancer ADC Specialist Myricx Bio Secures £90m in Funding Expanding Pipeline and Board

Cancer ADC Specialist Myricx Bio Secures £90m in Funding Expanding Pipeline and Board

BIOT

📢 Novo Holdings AS and Abingworth co-lead £90m financing in Myricx Bio Ltd, with plans to expand their ADC platform. 💰

featured image of Anacura Expands Services with OHMXbio Acquisition

Anacura Expands Services with OHMXbio Acquisition

BIOT

📢 Anacura acquires OHMX.bio! Expanding services in drug discovery and diagnostics research. Strengthening biotech community with personalized lab solutions.

featured image of EMA Approves 10 New Life-Changing Medicines!

EMA Approves 10 New Life-Changing Medicines!

BIOT

📢 EMA's CHMP recommended 10 medicines for approval in June 2024, including Balversa, Eurneffy, and mResvia. 💊👃💉

featured image of Belgian MedTech Firm Nyxoah Secures €375m Loan for Sleep Apnea Innovation

Belgian MedTech Firm Nyxoah Secures €375m Loan for Sleep Apnea Innovation

BIOT

🚀 Belgian medical tech company Nyxoah secures €37.5m loan from European Investment Bank for R&D and manufacturing expansion. ✨🔬💡

featured image of Boosting Biopharma Confidence with Cutting-Edge Tools

Boosting Biopharma Confidence with Cutting-Edge Tools

BIOT

🧪 Charles River Laboratories: Tools & services for efficient production & testing of cell, gene, & gene-modified therapy products. 🔬 Reference materials for assay development & validation. 🧬 Technology transfer & Flex Platform for cell therapy development. 💪 Accelerating new therapies with consistency & confidence.